КЛИНИЧЕСКАЯ ЭФФЕКТИВНОСТЬ СИМВАСТАТИНА В ТЕРАПИИ ЭНДОТЕЛИАЛЬНОЙ ДИСФУНКЦИИ У ПАЦИЕНТОВ С ВПЕРВЫЕ ВОЗНИКШИМ ИШЕМИЧЕСКИМ ИНСУЛЬТОМ

Abstract

Aim of this study was to estimate mortality and frequency of recurrent cardiovascular events, dynamics of neurological deficit, endothelial dysfunction and renal function in patients with the first-time ischemic stroke treated with simvastatin 40 mg/day in acute period of the disease. Simvastatin 40 mg/day (Zokor forte) prescribed along with neuroprotective and antihypertensive treatment in acute stage of ischemic stroke leads to lowering of recurrent cardiovascular events number, positive dynamics of neurological status, regression of endothelial dysfunction, associated with improved renal function.

Keywords

• ischemic stroke
• endothelial dysfunction
• renal function
• cardiovascular events
• simvastatin
• zokor forte